Access Grant Program

The Lung Cancer Initiative of North Carolina is currently awarding three Access Grants up to $10,000 each to assist institutions to improve access to lung cancer screening, treatment, clinical trials, molecular testing or precision medicine for uninsured or underinsured individuals.  Applications will be reviewed and Access Grants will be awarded to programs most closely meeting the focus areas outlined below.

Focus Areas

  • Programs that improve access to lung cancer screening, treatment, clinical trials, molecular testing or precision medicine.
  • Programs that provide culturally appropriate programming for uninsured or underinsured individuals, this includes services that are respectful of and responsive to the health beliefs, practices and cultural and linguistic needs of diverse patients.
  • Programs that engage in collaborations including but not limited to county collaborations, nonprofits, hospitals and community based organizations. 
  • Programs must have a direct impact on patients in North Carolina. 

Important Dates

Applications will be accepted all year until funds are depleted.  We will be reviewing applications quarterly according to this schedule:

Application Period Decision Communicated By
Jan 1, 2017 -  April 7, 2017 April 28, 2017
April 8, 2017 - July 7, 2017 July 28, 2017
July 7, 2017 - October 6, 2017 October 27, 2017

Eligibility

Applicants and institutions must meet the following eligibility requirements to apply:

  • Applicant must have tax exempt status under the IRS Code. 
  • Project must be specific to lung cancer. 
  • Individuals are not eligible to apply.

Access Grants Funds may NOT be used for the following purposes: 

  • Event sponsorship
  • Salaries and fringe benefits
  • Medical equipment
  • Medical or scientific research
  • Scholarships or fellowships
  • Indirect costs
  • Construction or renovation of facilities
  • Political campaigns or lobbying

Submission Requirements:

  • Organizational Profile
  • Project Overview 
  • Project Narrative
  • Key Personnel
  • Attachments
    • Project Budget and Justification
    • Certificate of Liability Insurance 
    • Proof of Non-profit Status 
    • Signed W-9
    • A letter of support from collaborating organizations
    • Evaluation Tool

Review Process

Each Application will be reviewed by at least three reviewers and will be considered based on the following selection criteria:

1. Impact: Will the project have a positive impact on increasing access for lung cancer patients? Will the project have a substantial impact on the priority selected? How closely does the project align with the focus areas stated in the RFA? Does the project have a sufficient and documented plan to evaluate its impact? 

2. Feasibility: How likely is it that the objectives and activities will be achieved within the scope of the funded project? Is the project well planned? Is the budget appropriate and realistic? Does the budget justification explain in detail the reasoning and need for the costs associated with the project? 

3. Capacity: Does the organization, Project Director and his/her team have the expertise and resources to effectively implement all aspects of the project? Is the organization respected and valued by the target population? Is it culturally competent?

4. Collaboration: Does this project enhance collaboration among organizations with similar or complementary goals? Are the roles of the partners appropriate and relevant?

5. Sustainability: Is the project likely to be sustained? Are partnerships likely to be sustained past project period? Is the impact likely to be long-term?

Apply Here

Connect With Us

  • Address: 4000 Blue Ridge Rd, Ste. 170 Raleigh, NC 27612
  • Telephone: 919-784-0410
  • Fax:  919-784-0416
  • Join our Mailing List

Follow Us